Blue Oak is set on restoring hope for patients with brain disorders by ending decades of stagnation in the development of new neuropsychiatric drugs. We offer a validated solution to the 40-year problem of discovering and developing truly novel mechanisms-of-action drugs for brain disorders.
As a startup biotech led by experienced drug hunters having demonstrated success in developing safe, effective therapies for patients suffering from mental illness, our proven systems neuroscience strategy works with AI partners in behavioral science and chemical structure to design privileged compounds that target brain circuitry and behavior. This strategy is effective in developing both first-in-class and best-in-class drugs for brain disorders.